Coastal Connecticut Research

At Coastal Connecticut Research, we review many trials for medications involving women's health, neurology, internal medicine and psychiatry. We strive to bring to our community trials that are respectful of the needs of our patients, and that will be likely to provide beneficial information to the medical community. These trials are sponsored by major pharmaceutical and biotechnology companies, and are all approved by the FDA.

A clinical trial is a research study of a medication, device or technology that is used to treat a particular medical condition in a particular population of people. The purpose of these studies is to find out whether an investigational medication is safe to use and effective for treatment of various medical conditions, or to compare existing medications that have been approved for the treatment of a particular condition.

JANUARY HEALTH CARE EVENTS AT NO COST
Evaluating volunteers for treatment for:

Hot Flashes:
Are you post-menopausal and experiencing several hot flashes a day? If so, you may be eligible to participate in a clinical research study to test the safety and effectiveness of an investigational medication, which is taken by mouth, in women who are experiencing moderate to severe vasomotor symptoms, commonly called hot flashes, associated with menopause.
You may be eligible to participate in this study if: You are a female over 40 years of age at time of your visit - You have more than 7-8 moderate to severe hot flashes per day (average) or 50-60 moderate to severe hot flashes per week for a least 30 days - You meet one of the following criteria: you have not had a period for at least 12 consecutive months or - you did not have a period for at least 6 months and meet the biochemical criteria for menopause (this is determined through standard laboratory test) or you have had both ovaries and fallopian tubes removed (with or without hysterectomy) for more than 5 weeks. Study participation last approximately 24 weeks and require approximately 6 visits to the doctor and 8 phone calls from the doctor's office. All study-related office visits, medical examinations, and the investigational medication will be provided to qualified study participants at no cost. Dr. Spitz's research office is conducting this study. (860) 443-4567.

Multiple Sclerosis:
Are You Currently Being Treated for a Relapsing Form of Multiple Sclerosis? A research study is currently being conducted to learn about patients' satisfaction and safety of Fingolimod compared to other MS drugs. You may qualify to participate if you: are between the ages of 18 and 65 - have been diagnosed with a relapsing form of MS - have taken a drug used to control your MS symptoms for months or longer. Call today to see if you may qualify: Qualified participants will receive study-related exams and study medication at no cost. Dr. Radin's research office is conducting this study. (860) 443-4567

website: www.CCRstudies.com